We are live on ! Find out more
IMA icon

ImageneBio Inc

49 hedge funds and large institutions have $344M invested in ImageneBio Inc in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 25 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

749% more capital inflows, than outflows

Capital inflows: $100M | Capital outflows: $11.8M

525% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 4

333% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 3

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

26% more funds holding

Funds holding: 39 → 49 (+10)

18.05% more ownership

Funds ownership: 58.23% → 76.28% (+18%)

Holders
49
Holders Change
+10
Holders Change %
+25.64%
% of All Funds
0.75%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
13
Increased
25
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

IMA Hedge Fund Activity: Q4 2021 in Review

49 of the 6,523 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q4 2021, worth a combined $344M — up 26% from $272M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new IMA positions and 3 closed out — a net gain of 10 holders — while 25 added to existing stakes and 4 trimmed.

The largest buyer was BlackRock, adding an estimated $11.9M. The largest seller was Fidelity Investments, cutting an estimated $4.16M.

  • 49 institutional investors held ImageneBio Inc (IMA) as of Q4 2021, up from 39 in Q3 2021.
  • Funds reported $344M of ImageneBio Inc stock for Q4 2021, up 26% quarter-over-quarter.
  • 13 funds opened new ImageneBio Inc positions in Q4 2021 and 3 closed out, a net change of +10 holders.
  • The largest ImageneBio Inc buyer in Q4 2021 was BlackRock, an estimated $11.9M added.
  • The largest ImageneBio Inc seller in Q4 2021 was Fidelity Investments, an estimated $4.16M sold.

Based on aggregated 13F filings for Q4 2021.